Literature DB >> 22571839

HIV-infected persons with bipolar disorder are less aware of memory deficits than HIV-infected persons without bipolar disorder.

Kaitlin Blackstone1, Alexis Tobin, Carolina Posada, Ben Gouaux, Igor Grant, David J Moore.   

Abstract

Episodic memory deficits are common in HIV infection and bipolar disorder, but patient insight into such deficits remains unclear. Thirty-four HIV-infected individuals without bipolar disorder (HIV+/BD-) and 47 HIV+ individuals with comorbid bipolar disorder (HIV+/BD+) were administered the Hopkins Verbal Learning Test-Revised and the Brief Visuospatial Memory Test-Revised to examine objective learning/memory functioning. Subjective memory complaints were assessed via the memory subscale of the Patient's Assessment of Own Functioning Inventory. HIV+/BD+ individuals performed poorer on tests of visual learning and visual/verbal recall than did HIV+/BD- participants (ps < .05). Memory complaints only predicted verbal learning (at a trend level, p = .10) and recall (p = .03) among the HIV+/BD- individuals. Memory complaints were not associated with memory performance within the HIV+/BD+ group (ps > .10). Memory complaints were associated with depressive symptoms in both groups (ps < 0.05). These complaints were also predictive of immunosuppression, higher unemployment, and greater dependence on activities of daily living among the HIV+/BD+ individuals (ps < .05). Awareness of memory abilities was particularly poor among HIV+/BD+ individuals (i.e., objective learning/memory did not correspond to reported complaints), which has important implications for the capacity of these individuals to engage in error-monitoring and compensatory strategies in daily life. Memory complaints are associated with depressed mood regardless of group membership. Among HIV+/BD+ individuals, these complaints may also signify worse HIV disease status and problems with everyday functioning. Clinicians and researchers should be cognizant of what these complaints indicate in order to lead treatment most effectively; use of objective neurocognitive assessments may still be warranted when working with these populations.

Entities:  

Mesh:

Year:  2012        PMID: 22571839      PMCID: PMC3718038          DOI: 10.1080/13803395.2012.682974

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  39 in total

Review 1.  The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings.

Authors:  S M Strakowski; M P Delbello; C M Adler
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

2.  Subjective complaints versus actual cognitive deficits in predominantly symptomatic HIV-1 seropositive individuals.

Authors:  L H Moore; W G van Gorp; C H Hinkin; M J Stern; T Swales; P Satz
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1997       Impact factor: 2.198

3.  Actual versus self-reported cognitive dysfunction in HIV-1 infection: memory-metamemory dissociations.

Authors:  C H Hinkin; W G van Gorp; P Satz; T Marcotte; R S Durvasula; S Wood; L Campbell; M R Baluda
Journal:  J Clin Exp Neuropsychol       Date:  1996-06       Impact factor: 2.475

4.  Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. III. Neurologic and neuropsychological findings.

Authors:  Y Stern; K Marder; K Bell; J Chen; G Dooneief; S Goldstein; D Mindry; M Richards; M Sano; J Williams
Journal:  Arch Gen Psychiatry       Date:  1991-02

5.  Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis.

Authors:  M Cherner; E Masliah; R J Ellis; T D Marcotte; D J Moore; I Grant; R K Heaton
Journal:  Neurology       Date:  2002-11-26       Impact factor: 9.910

6.  A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder.

Authors:  Lucy J Robinson; Jill M Thompson; Peter Gallagher; Utpal Goswami; Allan H Young; I Nicol Ferrier; P Brian Moore
Journal:  J Affect Disord       Date:  2006-03-06       Impact factor: 4.839

7.  WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings.

Authors:  M Maj; P Satz; R Janssen; M Zaudig; F Starace; L D'Elia; B Sughondhabirom; M Mussa; D Naber; D Ndetei
Journal:  Arch Gen Psychiatry       Date:  1994-01

8.  A meta-analytic investigation of neurocognitive deficits in bipolar illness: profile and effects of clinical state.

Authors:  Matthew M Kurtz; Raphael T Gerraty
Journal:  Neuropsychology       Date:  2009-09       Impact factor: 3.295

Review 9.  A role for white matter abnormalities in the pathophysiology of bipolar disorder.

Authors:  Katie Mahon; Katherine E Burdick; Philip R Szeszko
Journal:  Neurosci Biobehav Rev       Date:  2009-11-06       Impact factor: 8.989

10.  Neuropsychological performance, mood, and complaints of cognitive and motor difficulties in individuals infected with the human immunodeficiency virus.

Authors:  R L Mapou; W A Law; A Martin; D Kampen; A M Salazar; J R Rundell
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1993       Impact factor: 2.198

View more
  4 in total

1.  Attention-deficit/hyperactivity disorder among chronic methamphetamine users: frequency, persistence, and adverse effects on everyday functioning.

Authors:  Lisa C Obermeit; Jordan E Cattie; Khalima A Bolden; Maria J Marquine; Erin E Morgan; Donald R Franklin; J Hampton Atkinson; Igor Grant; Steven Paul Woods
Journal:  Addict Behav       Date:  2013-08-19       Impact factor: 3.913

2.  Lifetime suicide attempt history, quality of life, and objective functioning among HIV/AIDS patients with alcohol and illicit substance use disorders.

Authors:  Kimberly N Walter; Nancy M Petry
Journal:  Int J STD AIDS       Date:  2015-05-06       Impact factor: 1.359

3.  Real-world impact of neurocognitive deficits in acute and early HIV infection.

Authors:  Katie L Doyle; Erin E Morgan; Sheldon Morris; Davey M Smith; Susan Little; Jennifer E Iudicello; Kaitlin Blackstone; David J Moore; Igor Grant; Scott L Letendre; Steven Paul Woods
Journal:  J Neurovirol       Date:  2013-11-26       Impact factor: 2.643

Review 4.  The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review.

Authors:  Thomas M Gates; Lucette A Cysique
Journal:  CNS Drugs       Date:  2016-01       Impact factor: 5.749

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.